SeptRx Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $2.7M

  • Investors
  • 1

SeptRx General Information

Description

Provider of medical devices. The company develops specializes in minimally-invasive treatments for structural heart defects and develops Intrapocket PFO Occluder, a platform for the percutaneous transcatheter closure of a heart defect known as patent foramen ovale.

Contact Information

Website
www.septrx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 47533 Westinghouse Drive
  • Suite C
  • Fremont, CA 94539
  • United States
+1 (510)
Primary Industry
Surgical Devices
Corporate Office
  • 47533 Westinghouse Drive
  • Suite C
  • Fremont, CA 94539
  • United States
+1 (510)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SeptRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 06-Jun-2011 $2.7M Completed Startup
To view SeptRx’s complete valuation and funding history, request access »

SeptRx Patents

  • 27

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • Pending

  • Expiring in next 12 mo

SeptRx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2353827-T3 Device for the prevention of the unwanted passage of embols from a venous bloody deposit to an arterial bloody deposit. Active 20-Nov-2006
US-20080161825-A1 Anatomical measurement tool Inactive 20-Nov-2006
US-20080119886-A1 Mechanical tissue device and method Inactive 20-Nov-2006
DE-602007009915-D1 Device for preventing unwanted flow of emboli from the veins into the arteries Active 20-Nov-2006
EP-1923019-B1 Device for preventing the undesired passage of emboli from a venous blood pool to an arterial blood pool Inactive 20-Nov-2006 A61F2/01
To view SeptRx’s complete patent history, request access »

SeptRx Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Confluent Medical Technologies PE-Backed Company Minority
To view SeptRx’s complete investors history, request access »

Ready to get started?

Request a free trial

SeptRx FAQs

  • When was SeptRx founded?

    SeptRx was founded in 2011.

  • Where is SeptRx headquartered?

    SeptRx is headquartered in Fremont, CA.

  • What industry is SeptRx in?

    SeptRx’s primary industry is Surgical Devices.

  • Is SeptRx a private or public company?

    SeptRx is a Private company.

  • What is SeptRx’s current revenue?

    The current revenue for SeptRx is .

  • How much funding has SeptRx raised over time?

    SeptRx has raised $2.7M.

  • Who are SeptRx’s investors?

    Confluent Medical Technologies has invested in SeptRx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »